Literature DB >> 16360574

Treatment of nonaortic aneurysms in the endograft era: aneurysms of the innominate and subclavian arteries.

Christopher M Chambers1, John A Curci.   

Abstract

Although open aneurysm repair remains the standard of care, the advent of endoluminal techniques and stent grafts has significant potential to improve treatment of aneurysms of the innominate and subclavian arteries. Regardless of the modality chosen, therapy must be individualized and treatments tailored on the basis of anatomic and etiologic considerations. Occasionally, definitive treatment of an aneurysm with endoluminal stent-graft placement is possible for focal aneurysms or pseudoaneurysms of the innominate or subclavian arteries. In other situations, endoluminal grafting may be combined with open repair to allow for the benefits of both techniques. Ultimately long-term follow-up data are necessary to determine whether the durability of the endoluminal approach warrants more widespread use.

Entities:  

Mesh:

Year:  2005        PMID: 16360574     DOI: 10.1053/j.semvascsurg.2005.09.003

Source DB:  PubMed          Journal:  Semin Vasc Surg        ISSN: 0895-7967            Impact factor:   1.000


  3 in total

1.  Which Arteries Are Expendable? The Practice and Pitfalls of Embolization throughout the Body.

Authors:  Thomas R Burdick; Eric K Hoffer; Todd Kooy; Basavaraj Ghodke; Benjamin W Starnes; Karim Valji; Steve Goldberg; Danial Hallam; R Torrance Andrews
Journal:  Semin Intervent Radiol       Date:  2008-09       Impact factor: 1.513

2.  Successful surgical treatment of right subclavian artery aneurysm with a hypoplastic left vertebral artery using temporary cerebral perfusion to prevent cerebral ischemia.

Authors:  Hiroshi Ito; Hiroshi Kurazumi; Kensuke Sakata; Yurio Koabayashi
Journal:  Ann Vasc Dis       Date:  2011-03-26

3.  Hybrid Repair of an Aneurysm of the Innominate Artery.

Authors:  Peter-Jan Vancoillie; Karen Peeters; Sigi Nauwelaers; Luc Stockx; Geert Lauwers
Journal:  EJVES Vasc Forum       Date:  2021-10-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.